Stay updated on P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Locations section added with California as a site and revision updated to v3.3.3; HHS Vulnerability Disclosure and California Locations labels were removed.
    Difference
    0.2%
    Check dated 2025-12-24T14:49:00.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The only change is a revision update from v3.3.1 to v3.3.2 with no changes to study content visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:27:51.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.3.1 added; v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T13:48:18.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Funding-status notice removed. The page content remains focused on the study details and locations.
    Difference
    0.4%
    Check dated 2025-11-17T06:30:13.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected in the page context; the study details for NCT03113487 remain intact as presented. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:11:27.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    2%
    Check dated 2025-10-05T09:50:11.000Z thumbnail image

Stay in the know with updates to P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.